Latest Heart valve Stories

ST. LOUIS, May 25, 2011 /PRNewswire/ -- Missouri Baptist Medical Center cardiac surgeons and cardiologists are teaming up to provide better treatment options for patients with heart valve conditions. The new Heart Valve Clinic at Missouri Baptist opens June 3, offering patients with heart valve disease access to several specialists at one time in order to expedite their care and help determine the optimal treatment protocol in a setting that is convenient for the patient. "Valve disease...

KIRKLAND, Wash., May 4, 2011 /PRNewswire/ -- Cardiac Dimensions®, Inc. announced today the initiation of two new clinical studies using the CARILLON® Mitral Contour System(TM), an investigational device for percutaneous treatment of Functional Mitral Regurgitation (FMR). The CARILLON system is a minimally invasive device designed to repair the heart's mitral valve and reduce FMR, a disorder that affects most of the estimated 5 million people in the U.S. and more than 20 million people...

ZHENGZHOU, China, May 4, 2011 /PRNewswire-Asia-FirstCall/ -- China Valves Technology, Inc. (NASDAQ: CVVT) ("China Valves" or the "Company"), a leading Chinese metal valve manufacturer, today announced that the Company's management team will present at the 8th Annual Piper Jaffray China Growth Conference and the Oppenheimer 5th Annual China Dragon Call Conference. The date, time and location of China Valves' presentation at the 8th Annual Piper Jaffray China Growth Conference are as...

A gene known to be important in cardiac development has been newly associated with congenital heart malformations that result in obstruction of the left ventricular outflow tract. These are the findings from a study conducted by Nationwide Children's Hospital and appearing in the journal Birth Defects Research Part A.Left ventricular outflow tract (LVOT) malformations, including aortic valve stenosis, coarctation of the aorta, hypoplastic left heart syndrome, Shone complex and interrupted...

Open heart surgery can be avoided by some with a new type of heart valve that is placed through a tube in an artery, cardiologists report in a study.However, the downside would be a higher risk of stroke as well as uncertainty on how long these valves would last.Edwards LifeSciences Corp. developed a heart valve replacement technique that spares patients open heart surgery. It had a lower death rate than open heart surgery at one year.After one year, 24.2% of patients with the Edwards valve...

NorthShore University HealthSystem's Ted Feldman, MD, Presents Late Breaking Data at American College of Cardiology Conference EMBARGOED FOR RELEASE UNTIL 8 AM, CDT, APRIL 4, 2011 EVANSTON, Ill., April 4, 2011 /PRNewswire-USNewswire/ -- NorthShore University HealthSystem (NorthShore) interventional cardiologist, Ted Feldman, MD, presented positive results from the EVEREST II trial (Endovascular Valve Edge-to-Edge REpair STudy), that were concurrently published in The New England Journal of...

DETROIT, April 3, 2011 /PRNewswire/ -- A major new study presented today at the yearly scientific meeting of the American College of Cardiology (ACC) in New Orleans shows conclusively that replacing defective aortic valves in elderly patients through non-invasive "catheterization" - rather than through much more invasive open-heart surgery - leads to significantly better outcomes. The new clinical trial study (PARTNER cohort A: Transcatheter valves noninferior to surgery), documents...

NYU Langone Medical Center surgeons are performing minimally invasive heart surgery techniques on patients in their 80s and 90s. Outcomes are strong, going against the assumption that elderly patients who have heart surgery are destined to a steady decline. New York, NY (Vocus/PRWEB) March 31, 2011 NYU Langone Medical Center has performed minimally invasive heart surgery for over 15 years. In that time there has been an increase in elderly patients. Now 5% of the surgeries are performed...

ABBOTT PARK, Ill., March 30, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the launch of the company's catheter-based MitraClip® system for the treatment of mitral regurgitation (MR) in Australia. The MitraClip device, which has received Therapeutic Goods Administration (TGA) approval, offers a new treatment option for patients suffering from MR, a debilitating heart valve condition. Chronic, severe MR is often associated with heart failure and can result in death if left...

Research from Karolinska Institutet in Sweden shows, that a specific inflammatory factor may be important in the development of the heart valve disease aortic stenosis. The results suggest that anti-inflammatory medication could be a possible new treatment.Aortic stenosis is the most common heart valve disease, which is caused by calcium deposits and a narrowing of the aortic valve. This is typically seen in the elderly, but can also be caused by a congenital defect. Aortic stenosis is...